Oral Anticoagulant Therapy

Oral anticoagulant medications impair the process of clot formation and are used to prevent thromboembolic conditions like pulmonary embolism or stroke. They can also reduce the risk of transient ischemic attacks and myocardial infarction. There are three types of oral anticoagulant medications: vitamin K antagonists, like warfarin; direct thrombin inhibitors, like dabigatran; and direct factor Xa inhibitors, like rivaroxaban.

Okay, so, the main goal of coagulation is to form a stable blood clot to stop bleeding and allow time for the tissue to be repaired. Anticoagulants work by interfering with the normal function of clotting factors involved in the coagulation cascade. Now, the coagulation cascade consists of three pathways, the extrinsic, intrinsic, and common pathways, that interact together to form a stable blood clot.

The extrinsic and intrinsic pathways both lead into the final common pathway by independently activating factor X. After factor X is activated, it becomes factor Xa, and the common pathway begins. Here, factor Xa converts prothrombin to thrombin, which then cleaves fibrinogen, into fibrin. Fibrin is a long, thin protein that ultimately creates fibrin crosslinks to form a mesh that stabilizes the clot and helps stop bleeding.

Warfarin is a vitamin K antagonist. Vitamin K supports clotting by helping produce certain clotting factors in the coagulation cascade. So as a vitamin K antagonist, warfarin impairs the synthesis of these clotting factors, and prolongs clotting time, while also depleting the functional vitamin K reserves. Dabigatran, a direct thrombin inhibitor, and rivaroxaban, a direct factor Xa inhibitor, both prevent the formation of fibrin. Fibrin provides strength to stabilize the clot, so without it, clot production is disrupted.

Now, the most common side effect of anticoagulants is prolonged bleeding, ranging from minor hemorrhage and localized bruising to major hemorrhage. Hypersensitivity reactions like dermatitis or urticaria can also occur. Other side effects include nausea and abdominal pain. Looking more specifically at each medication, warfarin has a Black Box warning regarding the risk of causing potentially fatal bleeding events. Both dabigatran and rivaroxaban are less likely than warfarin to cause major bleeding events. Both medications have a Black Box warning for the risk of thrombotic events if they're discontinued prematurely. Their other side effects can include gastroesophageal reflux, esophagitis, or hemorrhagic gastritis.

Now, anticoagulants should not be given to patients with uncontrolled bleeding or thrombocytopenia or low platelet count; as well as recent eye, brain, or spinal cord surgery. Also, patients undergoing a lumbar puncture or having regional anesthesia should not take these medications. Patients with vitamin K deficiency, liver disease, or alcoholism should not take warfarin, since these conditions can impair the liver's ability to make clotting factors. Warfarin is also contraindicated in pregnancy due to its teratogenic effects, unless the patient has mechanical heart valves and is at high risk of thromboembolism. Patients with mechanical prosthetic heart valves should not take dabigatran or rivaroxaban. Lastly, all three oral anticoagulant medications are considered high risk medications, meaning the medications have an increased risk of causing significant harm if used in error.

Okay, so when caring for a patient on an anticoagulant, perform a baseline assessment including vital signs, and any signs or symptoms of bleeding like bruising, tarry stool, or abdominal pain. Then, review their most recent laboratory test results, such as CBC, and renal and liver function tests.

For your patient taking warfarin, review their international normalized ratio or INR value, and keep an anticoagulant antagonist, like vitamin K readily available, in case coagulation needs to be reversed. For your patient taking dabigatran or rivaroxaban, monitor the partial thromboplastin time or PTT, prothrombin time or PT, and platelet count. During care, monitor your patient closely for side effects, and evaluate the effectiveness of oral anticoagulant therapy.

Finally, when educating your patient about oral anticoagulant therapy, focus your teaching on safe self-administration. Be sure they understand why their medication is prescribed, the recommended length of treatment, and instruct them to take their medication exactly as directed. For patients taking warfarin, remind them of the importance of routine INR testing. Provide them with detailed information about how they can keep vitamin K in their diet consistent to ensure stability of their medication's effectiveness. For all patients taking anticoagulants, explain ways to limit bleeding and how to respond if bleeding occurs. Review other common side effects they may experience, and ensure they understand when they should notify their health care provider.

Alright, as a quick recap... Anticoagulant medications are used to impair the process of clot formation. Warfarin is a vitamin K antagonist that inhibits the formation of certain clotting factors. Dabigatran, a direct thrombin inhibitor, and rivaroxaban, a direct factor Xa inhibitor, both prevent the formation of fibrin used in the construction of clots. Common side effects include bleeding and GI disturbances. Nursing considerations include establishing a baseline assessment, monitoring for side effects, evaluating the effectiveness of therapy, and providing teaching for safe self-administration.